Idioma: Català | Castellano | English | Français traducido por Google translate

Obra Publicada

  • Pontes C, Zara C, Torrent-Farnell J, Obach M, Nadal C, et al. Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. Appl Health Econ Health Policy. 2020 Feb; 18(1):5-16.
  • Torrent-Farnell J, Comellas M, Poveda JL, Abaitua I, et al. The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus. Health Policy. 2018 Jun; 122(6):590-598.
  • Sacristán, J. M. F., Torrent-Farnell, J. Orphan drugs. Arbor, 2018; 194(789):a466.
  • Torrent-Farnell, J., Comellas, M., Poveda, J. L., Abaitua, I., Gutierrez-Solana, L. G., Perez-Lopez, J., ... & Lizán, L. The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: a Delphi consensus. Health Policy. 2018; 122(6):590-598.
  • Gilabert-Perramon A, Torrent-Farnell J, Catalan A, Prat A, Fontanet M, et al. Drug evaluation and decision making in catalonia: development and validation of a methodological framework based on multi-criteria decision analysis (mcda) for orphan drugs. Int J Technol Assess Health Care. 2017 Jan; 33(1):111-120.
  • Giannuzzi V, Landi A, Bosone E, Giannuzzi F, Nicotri S, Torrent-Farnell J, et al. Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs. BMJ Open. 2017 Sep 11; 7(9):e017358.
  • Torrent-Farnell, J. Situación actual de las enfermedades minoritarias: ¿Qué hemos conseguido hasta ahora?. I Reunión enfermedades minoritarias, 8 de juliol de 2011. [Accés web]
  • Haffner ME, Torrent-Farnell J, Maher PD. Does orphan drug legislation really answer the needs of patients? Lancet. 2008 Jun 14;371(9629):2041-2044.
  • Avellaneda A, Izquierdo M, Torrent-Farnell J, Ramón JR. [Rare Diseases: chronic diseases that need a new approach]. An Sist Sanit Navar. 2007 May-Aug; 30(2):177-190.
  • Torrent-Farnell, J.; Nolla, Maria; Grau, O. La Fundació doctor Robert (UAB) i el desenvolupament professional en ciències de la salut. Annals de medicina. 2006; 89(2):64-66,
  • Torrent-Farnell, J., & Morros, R. The EU challenges on the designation of orphan medicinal products. Pharmaceuticals Policy and Law. 2001; 3:19-30.